The high rate of unintended pregnancy in the United States suggests an unmet need for effective, patient-friendly birth control methods. The FDA has recently approved a nonhormonal, coitally dependent, user-controlled contraceptive that may help fill this gap.
In this activity, Drs. Eisenberg and Portman and Ms. Cason will discuss the role of vaginal pH modulators in contraception and how the current contraceptive trial design has contributed to the “creeping Pearl Index.”
This was a live broadcast, the Q&A portion is no longer available.